ID18181A - Senyawa-senyawa baru - Google Patents

Senyawa-senyawa baru

Info

Publication number
ID18181A
ID18181A IDP972341A ID972341A ID18181A ID 18181 A ID18181 A ID 18181A ID P972341 A IDP972341 A ID P972341A ID 972341 A ID972341 A ID 972341A ID 18181 A ID18181 A ID 18181A
Authority
ID
Indonesia
Prior art keywords
sub
alkyl
optionally substituted
group
compound
Prior art date
Application number
IDP972341A
Other languages
English (en)
Inventor
Carlo Dr Farina
Stefania Dr Gagliardi
Guy Marguerite Marie Ge Nadler
Original Assignee
Smithkline Beecham Spa
Smithkline Beecham Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614367.2A external-priority patent/GB9614367D0/en
Priority claimed from GBGB9626697.8A external-priority patent/GB9626697D0/en
Priority claimed from GBGB9626700.0A external-priority patent/GB9626700D0/en
Application filed by Smithkline Beecham Spa, Smithkline Beecham Lab filed Critical Smithkline Beecham Spa
Publication of ID18181A publication Critical patent/ID18181A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP972341A 1996-07-09 1997-07-07 Senyawa-senyawa baru ID18181A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9614367.2A GB9614367D0 (en) 1996-07-09 1996-07-09 Novel compounds
GBGB9626697.8A GB9626697D0 (en) 1996-12-23 1996-12-23 Novel compounds
GBGB9626700.0A GB9626700D0 (en) 1996-12-23 1996-12-23 Novel compounds

Publications (1)

Publication Number Publication Date
ID18181A true ID18181A (id) 1998-03-12

Family

ID=27268385

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972341A ID18181A (id) 1996-07-09 1997-07-07 Senyawa-senyawa baru

Country Status (21)

Country Link
US (2) US20020173659A1 (id)
EP (1) EP0914321B1 (id)
JP (1) JP2000514074A (id)
KR (1) KR20000023646A (id)
AT (1) ATE277037T1 (id)
AU (1) AU3620597A (id)
BR (1) BR9710230A (id)
CA (1) CA2259598A1 (id)
CZ (1) CZ3799A3 (id)
DE (1) DE69730837T2 (id)
ES (1) ES2229375T3 (id)
ID (1) ID18181A (id)
IL (1) IL127668A0 (id)
MA (1) MA24349A1 (id)
NO (1) NO990080L (id)
PE (1) PE46699A1 (id)
PL (1) PL330994A1 (id)
TR (1) TR199900138T2 (id)
TW (1) TW397684B (id)
UY (2) UY24608A1 (id)
WO (1) WO1998001443A1 (id)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420375B1 (en) 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
TR200003377T2 (tr) * 1998-05-15 2001-03-21 American Home Products Corporation Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
SE9903610D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds II
SE9903611D0 (sv) * 1999-10-06 1999-10-06 Astra Ab Novel compounds III
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
DE10022925A1 (de) * 2000-05-11 2001-11-15 Basf Ag Substituierte Indole als PARP-Inhibitoren
ATE366569T1 (de) 2000-07-20 2007-08-15 Lauras As Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
US20040259909A1 (en) * 2001-10-16 2004-12-23 Mccarthy Dennis Treatment of fibromyalgia syndrome
RU2005106274A (ru) 2002-09-06 2005-11-10 Янссен Фармацевтика, Н.В. (Be) Гетероциклические соединения
EP1567523B1 (en) * 2002-11-25 2008-08-20 F.Hoffmann-La Roche Ag Indolyl derivatives
US6916852B2 (en) * 2003-05-12 2005-07-12 University Of Tennessee Research Foundation Method for regulation of microvascular tone
ITMI20040875A1 (it) * 2004-04-30 2004-07-30 Ist Naz Stud Cura Dei Tumori Derivati indolici utili per il trattamento della resistenza agli agenti antitumorali
EP1779849A1 (en) 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase inhibitors for the treatment of septic shock
EP1779848A1 (en) 2005-10-28 2007-05-02 Nikem Research S.R.L. V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases
US20110038852A1 (en) * 2009-06-10 2011-02-17 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
CA2877474A1 (en) * 2011-06-20 2012-12-27 Myrexis, Inc. Compounds and therapeutic uses thereof
US20230219881A1 (en) * 2022-01-11 2023-07-13 Compound Solutions Inc. Synthesis of Spermidine, Spermine, and Free Bases Thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038925A1 (en) * 1990-03-26 1991-09-27 Takashi Sohda Indole derivatives, their production and use
WO1993001280A1 (en) * 1991-07-08 1993-01-21 Roland Baron Inhibition of proton pump in osteoclast cells
JPH07223945A (ja) * 1994-02-10 1995-08-22 Snow Brand Milk Prod Co Ltd 骨疾患治療剤
BR9606743A (pt) 1995-01-10 1997-12-30 Smithkline Beecham Spa Derivados indol úteis no tratamento de osteoporose

Also Published As

Publication number Publication date
IL127668A0 (en) 1999-10-28
KR20000023646A (ko) 2000-04-25
US20020173659A1 (en) 2002-11-21
US6903117B2 (en) 2005-06-07
JP2000514074A (ja) 2000-10-24
MA24349A1 (fr) 1998-07-01
NO990080D0 (no) 1999-01-08
EP0914321B1 (en) 2004-09-22
PL330994A1 (en) 1999-06-21
US20040010012A1 (en) 2004-01-15
DE69730837T2 (de) 2005-09-29
PE46699A1 (es) 1999-06-12
ES2229375T3 (es) 2005-04-16
WO1998001443A1 (en) 1998-01-15
CA2259598A1 (en) 1998-01-15
EP0914321A1 (en) 1999-05-12
AU3620597A (en) 1998-02-02
CZ3799A3 (cs) 1999-08-11
BR9710230A (pt) 1999-08-10
ATE277037T1 (de) 2004-10-15
TW397684B (en) 2000-07-11
TR199900138T2 (xx) 1999-04-21
UY24608A1 (es) 1997-12-19
DE69730837D1 (de) 2004-10-28
NO990080L (no) 1999-01-08
UY24802A1 (es) 2001-03-16

Similar Documents

Publication Publication Date Title
ID18181A (id) Senyawa-senyawa baru
BG101769A (en) Indole derivatives useful in the treatment of osteoporosis
MX9804107A (es) Derivados de quinolina.
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
GEP19970661B (en) Process for preparing arylcyclobutyl alkylamine derivatives
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
AU6052594A (en) New heterocyclic compounds
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
AU2337097A (en) Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
NZ507144A (en) Benzamide derivatives useful for the treatment of diseases mediated by cytokines
ES8801787A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos
IL107869A0 (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IL126278A0 (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
NZ505060A (en) 2-Aryl or heterocyclyl substituted indole derivatives useful for the treatment of osteoporosis
DE69719974D1 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69330601D1 (de) Serotoninergische ergolin derivate
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
GR3033333T3 (en) Carbamoyl carboxylic acid amides
ES8305336A1 (es) &#34;un metodo de preparar una 4-ariloxi-1,2,3,4-tetrahidroisoquinoleina&#34;.
NZ275620A (en) 3-optionally substituted phenyl or naphthyl-1,2,4-triazole derivatives; pharmaceutical compositions
MY108027A (en) Substitute tetrahydroisoquinolines and use as therepuetic agents